Solara Active Pharma Sciences Limited reported earnings results for the third quarter and nine months ended December 31, 2022. For the third quarter, the company reported sales was INR 3,947.5 million compared to INR 1,003.4 million a year ago. Revenue was INR 4,019.2 million compared to INR 1,050.7 million a year ago. Net income was INR 4.5 million compared to net loss of INR 1,398.7 million a year ago. Basic earnings per share from continuing operations was INR 0.12 compared to basic loss per share from continuing operations of INR 38.93 a year ago. Diluted earnings per share from continuing operations was INR 0.12 compared to diluted loss per share from continuing operations of INR 38.93 a year ago.
For the nine months, sales was INR 10,631.9 million compared to INR 9,075.2 million a year ago. Revenue was INR 10,810.6 million compared to INR 9,214.7 million a year ago. Net loss was INR 259.4 million compared to INR 600.3 million a year ago. Basic loss per share from continuing operations was INR 7.21 compared to INR 16.71 a year ago. Diluted loss per share from continuing operations was INR 7.21 compared to INR 16.71 a year ago.